Biopticon

Princeton, United States Founded: 2003 • Age: 23 yrs
Device and software imaging of subcutaneous tumors in animals
Request Access

About Biopticon

Biopticon is a company based in Princeton (United States) founded in 2003.. Biopticon offers products and services including TumorImager 2 and TumorManager. Biopticon operates in a competitive market with competitors including NavVis, Impedimed, Rigaku, Speclipse and Anvajo, among others.

  • Headquarter Princeton, United States
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Biopticon Corporation
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Robotics, Automation & Advanced Manufacturing
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    NJEDA

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Biopticon

Biopticon offers a comprehensive portfolio of products and services, including TumorImager 2 and TumorManager. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides fast and accurate 3D measurements of subcutaneous tumors in small animals.

Manages preclinical oncology studies from design to reporting and analysis.

Funding Insights of Biopticon

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2009 Amount Seed - Biopticon Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Biopticon

Biopticon has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NJEDA and RCTC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Economic development services are provided by NJEDA in New Jersey.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Biopticon

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Biopticon

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biopticon Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Biopticon

Biopticon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NavVis, Impedimed, Rigaku, Speclipse and Anvajo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Digital twin-powered indoor navigation solutions are developed for enterprises.
domain founded_year HQ Location
Technologies for non-invasive fluid status assessment and monitoring are developed.
domain founded_year HQ Location
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
domain founded_year HQ Location
Molecular spectroscopy systems for early skin cancer detection are provided.
domain founded_year HQ Location
Point-of-care solutions for laboratory diagnostics are provided by Anvajo.
domain founded_year HQ Location
3D cameras and scanners are provided for object capture.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Biopticon

Frequently Asked Questions about Biopticon

When was Biopticon founded?

Biopticon was founded in 2003 and raised its 1st funding round 6 years after it was founded.

Where is Biopticon located?

Biopticon is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.

What does Biopticon do?

Biopticon makes a hand-held imaging device that uses laser, photonics and image processing technologies to analyze subcutaneous tumors. The companys devices, TumorImager and TumorImager2, rapidly scan subcutaneous tumors (1 sec) without requiring the animal to be under anesthesia, providing highly sensitive, reproducible measurement of drug response. The instruments are meant for use on animals, especially for the study of subcutaneous xenograft tumors in rodents. Biopticon also makes a software product, TumorManager, which is a fully integrated platform that allows scientists to manage every aspect of subcutaneous xenograft studies from protocol design, randomization, dosing, data capture, graphics and statistical analysis. Customers include pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

Who are the top competitors of Biopticon?

Biopticon's top competitors include NavVis, Revopoint 3D and Impedimed.

What products or services does Biopticon offer?

Biopticon offers TumorImager 2 and TumorManager.

Who are Biopticon's investors?

Biopticon has 2 investors. Key investors include NJEDA, and RCTC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available